Abaxis Launches Quantitative Canine Lyme Disease Test



Published:

Abaxis Inc. added a quantitative antibody test for canine Lyme disease to its line of tests available through the Abaxis Veterinary Reference Laboratories Division in Olathe, Kan., the company reported today.

The test measures a combination of antibodies to peptides which mimic certain antigens of the Borrelia burgdorferi spirochete. The antibodies are not found in vaccinated or noninfected patients, allowing for a definitive diagnosis of the disease, according to Kenneth Aron, Ph.D., Abaxis' chief technology officer.

The test may be used as a standalone diagnostic test to determine infection status or efficacy during treatment. It also may be used as a quantitative confirmation test for Abaxis’ upcoming VetScan Lyme Rapid Test, which is under development, according to the Union City, Calif.-based company.

<HOME>

Edit Module
Edit ModuleShow Tags

Archive »Read More

New Fast-Acting Gel Designed to Stop Blood Loss

Plant-based Vetigel may be used in biopsies, emergency care and other situations.

DoveLewis, Vetstream Vow to Make a World of Difference

Veterinarians, students and staff living in the developing world gain access to low-cost or free educational material.

AAHA Hospitals in Ohio Can Skip State Inspections

106 accredited clinics are deemed good enough to forgo government examinations.

Add your comment:
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module